Table 8 Multivariate analysis of the correlation between side effects, education, staging, and follow-up time with the risk of interrupting EP treatment
Side Effect | "p" Value of Univariate Analysis | Univariate Analysis OR (CI) | "p" Value of Adjusted Analysis | Adjusted Analysis OR (CI) |
|---|---|---|---|---|
Spotting | < 0.001 | 4.267 (2.028–8.978) | < 0.001 | 8.432 (2.632–27.014) |
Persistence of Pain | 0.117 | 1.769 (0.898–3.610) | 0.006 | 6.388 (1.721–23.714) |
Infertility | 0.136 | 0.533 (0.234–1.218) | 0.010 | 0.153 (0.037–0.632) |
Duration of Treatment Less than 9 Months | 0.041 | 3.291 (1.048–10.335) | 0.067 | 4.550 (0.8990–23.009) |
Staging Minimal/Mild | 0.155 | 2.106 (0.755–5.874) | 0.026 | 5.578 (1.233–25.233) |
University Degree | 0.236 | 0.636 (0.331–1.344) | 0.429 | 0.619 (0.188–2.032) |
Headache | 0.299 | 2.348 (0.469–11.742) | 0.435 | 2.741 (0.217–34.491) |